Thus, although the other identified biomarkers (MMP-1/MMP-3/SAA) contributed to the understanding of SDFR in RA, these biomarkers (individually or when combined) are apparently not essential for the clinical identification of these patients. The gene discussed is MMP1; the disease is rheumatoid arthritis.